Clinical impact of nocturnal ventricular tachyarrythmias in electrical storm.


Journal

Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944

Informations de publication

Date de publication:
11 2022
Historique:
revised: 28 08 2022
received: 04 07 2022
accepted: 09 09 2022
pubmed: 17 9 2022
medline: 16 11 2022
entrez: 16 9 2022
Statut: ppublish

Résumé

The incidence of electrical storm (ES) is significantly higher during the daytime. However, the association between nocturnal ventricular tachyarrythmias during ES and prognosis remains unclear. Therefore, this study aimed to investigate the clinical characteristics and outcomes of ES with midnight ventricular tachyarrythmias. We included 48 consecutive patients who had an implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillator implanted between 2010 and 2020 and those who had experienced the onset of an out-of-hospital ES episode. According to the midnight (0:00 a.m.-6:00 a.m.) occurrence of ventricular arrythmia events consisting of ventricular tachycardia (VT) and ventricular fibrillation (VF), we divided them into two groups (with-midnight group: n = 27, without-midnight group: n = 21). The clinical characteristics and outcomes of the two groups were compared. The patients in the with-midnight group were mostly males, had longer QRS duration, and longer corrected QT-interval than those in the without-midnight group (p < .05). The incidence of all-cause death, especially heart failure death, was higher in the with-midnight group than in the without-midnight group (p < .01). Multivariate analysis showed that the presence of midnight VT/VF during ES was the only independent risk factors for heart failure death (HR = 18.9, 95%CI = 1.98-181, p = .011). The presence of midnight VT/VF during ES might be associated with the poor prognosis. The loss of a sympathetic circadian pattern of VT/VF distribution during ES might suggest advanced stages of the cardiac disease.

Sections du résumé

BACKGROUND
The incidence of electrical storm (ES) is significantly higher during the daytime. However, the association between nocturnal ventricular tachyarrythmias during ES and prognosis remains unclear. Therefore, this study aimed to investigate the clinical characteristics and outcomes of ES with midnight ventricular tachyarrythmias.
METHODS
We included 48 consecutive patients who had an implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillator implanted between 2010 and 2020 and those who had experienced the onset of an out-of-hospital ES episode. According to the midnight (0:00 a.m.-6:00 a.m.) occurrence of ventricular arrythmia events consisting of ventricular tachycardia (VT) and ventricular fibrillation (VF), we divided them into two groups (with-midnight group: n = 27, without-midnight group: n = 21). The clinical characteristics and outcomes of the two groups were compared.
RESULTS
The patients in the with-midnight group were mostly males, had longer QRS duration, and longer corrected QT-interval than those in the without-midnight group (p < .05). The incidence of all-cause death, especially heart failure death, was higher in the with-midnight group than in the without-midnight group (p < .01). Multivariate analysis showed that the presence of midnight VT/VF during ES was the only independent risk factors for heart failure death (HR = 18.9, 95%CI = 1.98-181, p = .011).
CONCLUSIONS
The presence of midnight VT/VF during ES might be associated with the poor prognosis. The loss of a sympathetic circadian pattern of VT/VF distribution during ES might suggest advanced stages of the cardiac disease.

Identifiants

pubmed: 36111963
doi: 10.1111/pace.14592
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1330-1337

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Behnes M, Müller J, Ellguth D, et al. Electrical storm is associated with impaired prognosis compared to ventricular tachyarrhythmias. Int J Cardiol. 2019;292:119-125.
Guerra F, Shkoza M, Scappini L, Flori M, Capucci A. Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis. Europace. 2014;16:347-353.
Huang DT, Traub D. Recurrent ventricular arrhythmia storms in the age of implantable cardioverter defibrillator therapy: a comprehensive review. Prog Cardiovasc Dis. 2008;51:229-236.
Guerra F, Bonelli P, Flori M, et al. Temporal trends and temperature-related incidence of electrical storm: the TEMPEST Study (Temperature-Related Incidence of Electrical Storm). Circ Arrhythm Electrophysiol. 2017;10:e004634.
Martins R, Urien J, Barbarot N, et al. Effectiveness of deep sedation for patients with intractable electrical storm refractory to antiarrhythmic drugs. Circulation. 2020;142:1599-1601.
Do D, Bradfield J, Ajijola O, et al. Thoracic epidural anesthesia can be effective for the short-term management of ventricular tachycardia storm. J Am Heart Assoc. 2017;6:e007080.
Thayer JF, Lane RD. The role of vagal function in the risk for cardiovasculardisease and mortality. Biol Psychol. 2007;74:224-242.
Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomicimbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2010;141:122-131.
Songwen C, Guannan M, Anisiia D, et al. Skin sympathetic nerve activity and the short-term QT interval variability in patients with electrical storm. Front Physiol. 2021;12:742844.
Koeniga J, Thayer JF. Sex differences in healthy human heart rate variability: a meta-analysis. Neurosci Biobehav Rev. 2016;64:288-310.
Sesselberg HW, Moss AJ, McNitt S, et al. Ventricular arrhythmia storms in post infarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm. 2007;4:1395-1402.
Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, et al. Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace. 2005;7:184-192.
Brigadeau F, Kouakam C, Klug D, et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J. 2006;27:700-707.
Streitner F, Kuschyk J, Veltmann C, Mahl E, et al. Predictors of electrical storm recurrences in patients with implantable cardioverter-defibrillators. Europace. 2011;13:668-674.
Arya A, Haghjoo M, Dehghani MR, et al. Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator. Am J Cardiol. 2006;97:389-392.
Dhar R, Alsheikh-Ali AA, Estes 3rd NA, et al. Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Heart Rhythm. 2008;5:807-813.
Englund A, Behrens S, Wegscheider K, et al. Circadian variation of malignant ventricular arrhythmias in patients with ischemic and nonischemic heart disease after cardioverter defibrillator implantation. J Am Coll Cardiol. 1999;34:1560-1568.
Assis FR, Camm CF, BM AnnelineR, et al. Nocturnal premature ventricular contraction burden as a marker of disease severity in arrhythmogenic right ventricular cardiomyopathy. JACC Clin Electrophysiol. 2017;3:1607-1608.
Schwartz PJ, Crotti L, Insolia R. Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol. 2012;5:868-877.
Conraads VM, Spruit MA, Braunschweig F, et al. Physical activity measured with implanted devices predicts patient outcome in chronic heart failure. Circ Heart Failure. 2014;7:279-287.
Walsh JT, Charlesworth A, Andrews R, et al. Relation of daily activity levels in patients with chronic heart failure to long-term prognosis. Am J Card. 1997;79:1364-1369.
Sun X, Zhou B, Chen K, et al. Association of night-time heart rate with ventricular tachyarrhythmias, appropriate and inappropriate implantable cardioverter-defibrillator shocks. Front Cardiovasc Med. 2021;8:739889.
Böhm M, Schumacher H, Teo KK, et al. Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials. Eur Heart J. 2020;41:231-238.
Seviiri M, Lynch BM, Hodge AM, et al. Resting heart rate, temporal changes in resting heart rate, and overall and causespecific mortality. Heart. 2018;104:1076-1085.
Zhao S, Chen K, Su Y, et al. The role of variability in night-time mean heart rate on the prediction of ventricular arrhythmias and all-cause mortality in implantable cardioverter defibrillator patients. Europace. 2015;17(Suppl. 2):ii76-ii82.
Khan H, Kunutsor S, Kalogeropoulos AP, et al. Resting heart rate and risk of incident heart failure: three prospective cohort studies and a systematic meta-analysis. J Am Heart Assoc. 2015;4:e001364.
Guerra F, Flori M, Bonelli P, et al. Electrical storm and heart failure worsening in implantable cardiac defibrillator patients. Europace. 2015;17:247-254.
Verrier RL, Josephson ME. Impact of sleep on arrhythmogenesis. Circ Arrhythm Electrophysiol. 2009;2:450-459.

Auteurs

Naomasa Suzuki (N)

Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Sou Otsuki (S)

Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Daisuke Izumi (D)

Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Rie Akagawa (R)

Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Yuta Sakaguchi (Y)

Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Takahiro Hakamata (T)

Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Yasuhiro Ikami (Y)

Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Yuki Hasegawa (Y)

Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Nobue Yagihara (N)

Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Kenichi Iijima (K)

Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Masaomi Chinushi (M)

Niigata University School of Medicine, Niigata, Japan.

Takayuki Inomata (T)

Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH